PROSPECTS TO IMPROVE LONG-TERM OUTCOMES OF CARDIAC TRANSPLANTATION
https://doi.org/10.15825/1995-1191-2014-3-23-30
Abstract
The analysis of clinical outcomes of cardiac transplantation is presented. The main directions of research on the development and implementation of methods for early diagnosis of adverse events and treatment of patients with heart transplant in V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation are given. Among the non-invasive methods of forecasting, assessment of the risk of cardiovascular complications in heart recipients being developed are: analysis of laboratory biomarkers involved in the formation of relationship of the graft and the recipient; ultrasound diagnosis of functional and structural remodeling of peripheral arteries. The issues of improving drug therapy are discussed. The importance of multidisciplinary approach, continuity in management of the patients with heart transplant is emphasized.
About the Authors
S. V. Gautier
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
I.M. Sechenov First Moscow State Medical University, Department of transplantology
and artifi cial organs, Moscow, Russian Federation
Russian Federation
Russian Federation
academician of the RAS, professor, Director Academician V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation, Head of
department of transplantology and artifi cial organs, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
A. O. Shevchenko
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Department of cardiology, Moscow, Russian Federation
Russian Federation
Russian Federation
professor of department of cardiology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation; chief research fellow, department of coordination and monitoring of research program at the same center
A. Ya. Kormer
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation
Russian Federation
leading research fellow, department of cardiac surgery, heart and lung transplantation at the same center
V. N. Poptsov
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation
Russian Federation
professor, deputy director of high technology programs implementation, head of department of anesthesiology and intensive therapy at the same center
O. P. Shevchenko
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
I.M. Sechenov First Moscow State Medical University, Department of transplantology
and artifi cial organs, Moscow, Russian Federation
Russian Federation
Russian Federation
professor, deputy director of scientifi c research, head of department of regulatory mechanisms in transplantology at the same center; professor of the department of transplantology and artifi cial organs, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
References
1. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J. 2004; 25: 1614–1619.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ et al. Heart Disease and Stroke Statistics-2014 Update: A Report From the American Heart Association. Circulation. 2014; 129: e28–e292. doi: 10.1161/01.cir.0000441139.02102.80.
3. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012; 14 (8): 803–869. doi: 10.1093/eurheartj/ehs104.
4. Мареев ВЮ, Агеев ФГ, Арутюнов ГП, Коротеев АВ, Мареев ЮВ, Овчинников АГ. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН. Сердечная недостаточность. 2013; 7 (81): 379–472. Mareev VYu, Ageev FG, Arutyunov GP, Koroteev AV, Mareev YuV, Ovchinnikov AG. Natsional'nye rekomendatsii OSSN, RKO i RNMOT po diagnostike i lecheniyu KhSN. Serdechnaya nedostatochnost'. 2013; 7 (81): 379–472.
5. Готье СВ, Мойсюк ЯГ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации в 2013 году. VI сообщение Регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2014; XVI (2): 5–23. Gautier SV, Moĭ syuk YaG, Khomyakov SM. Donorstvo i transplantatsiya organov v Rossiĭ skoĭ Federatsii v 2013 godu. VI soobshchenie Registra Rossiĭ skogo transplantologicheskogo obshchestva. Vestnik ransplantologii i iskusstvennykh organov = Russian Journal of Transplantology and Artifi cial Organs. 2014; XVI (2): 5–23.
6. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Offi cial Adult Heart Transplant Report – 2013; Focus Theme: Age. J Heart Lung Transplant. 2013; 32 (10): 951–964. doi: 10.1016/j.healun.2013.08.006.
7. Costello JP, Mohanakumar T, Nath DS. Mechanisms of chronic cardiac allograft rejection. Tex Heart Inst J. 2013; 40 (4): 395–399. 8. Нershberger RE, Starling RC, Eisen HJ, Bergh CH, Kormos RL, Love RB et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med. 2005; 352 (26): 2705–2713.
8. Eisen HJ, TuzcuEM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA et al. verolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003; 349: 847–858. doi: 10.1056/NEJMoa022171.
9. Kobashigawa JW, Miller LW, Felker GM, Russel SD, Ewald GA, Zucker M et al. 12 month report of a 3 arm multicenter comparison of Tacrolimus (TAC), MMF or TAC / Sirolimus(SRL) and steroids vs cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients. J Heart Lung Transplant. 2005; 24: S61–S61. doi: 10.1016/j.healun.2004.11.084.
10. Sharon AH., François Haddad. The changing face of heart transplantation. J Am Coll Cardiol. 2008; 52 (8): 587–598. doi:10.1016/j.jacc.2008.05.020.
11. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008; 117 (16): 2131–2141. doi:10.1161/CIRCULATIONAHA.107.711911.
12. Martínez-Dolz L, Almenar L, Reganon E, Vila V, Sánchez-Soriano R, Martínez-Sales V et al. What is the best biomarker for diagnosis of rejection in heart transplantation? Clin Transplant. 2009; 23 (5): 672–680. doi: 10.1111/j.1399-0012.2009.01074.x.
13. Шумаков ВИ, Шевченко ОП, Хубутия МШ, Орлова ОВ, Казаков ЭН, Кормер АЯ и др. Васкулопатия трансплантированного сердца: синергизм провоспалительных, проатерогенных факторов и вирусной инфекции. Вестник РАМН. 2006; 11: 8–14. Shumakov VI, Shevchenko OP, Khubutiya MSh, Orlova OV, Kazakov EN, Kormer AYa et al. Vaskulopatiya transplantirovannogo serdtsa: sinergizm provospalitel'nykh, proaterogennykh faktorov i virusnoĭ infektsii. Vestnik RAMN. 2006; 11: 8–14.
14. Belperio JA, Ardehali A. Chemokines and transplant vasculopathy. Circ Res. 2008; 103 (5): 454–466. doi: 10.1161/CIRCRESAHA.108.182865.
15. Marasco SF, Sheeran FL, Chaudhuri K, Vale M, Bailey M, Pepe S. Molecular markers of programmed cell death in donor hearts before transplantation. J Heart Lung Transplant. 2014; 33 (2): 185–193. doi: 10.1016/j.healun.2013.10.013.
16. Shevchenko OP, Khalilulin TA, Shevchenko AO, Apanasenko NV, Stakhanova EA, Kormer AJ et al. Predictive Value of PAPP-A, sCD40L, Anti-HLA Antibodies Detected By ELISA and Luminex in Heart Transplant Recipients. J Heart Lung Transplant. 2013; 33 (4): 135. doi: 10,1016 / j.healun.2014.01.363.
17. Шевченко АО, Тюняева ИЮ, Насырова АА, Миронков БЛ, Куприянова АГ, Ильинский ИМ. Жесткость сосудистой стенки общей сонной артерии у пациентов после трансплантации сердца. Вестник трансплантологии и искусственных органов (ПРИЛОЖЕНИЕ). 2014; XVI: 184–185. Shevchenko AO, Tyunyaeva IYu, Nasyrova AA, Mironkov BL, Kupriyanova AG, Il'inskiĭ IM. Zhestkost' sosudistoĭ stenki obshcheĭ sonnoĭ arterii u patsientov posle transplantatsii serdtsa. Vestnik transplantologii i iskusstvennykh organov = Russian Journal of Transplantology and Artifi cial Organs (Supplement). 2014; XVI: 184–185.
18. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant. 2002; 2: 807–818.
19. Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A et al. Association of angiotensin converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006; 82 (8): 1108–1111.
20. Raichlin ER, McConnell JP, Lerman A, Kremers WK, Edwards BS, Kushwaha SS et al. Systemic infl ammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant. 2007; 26 (8): 826–833.
21. Шевченко ОП, Халилулин ТА, Шевченко АО, Захаревич ВМ, Кунцевич НВ, Муминов ИИ. Нелипидные и противовоспалительные эффекты розувастатина у реципиентов сердца. Врач. 2013; 5: 76–79. Shevchenko OP, Khalilulin TA, Shevchenko AO, Zakharevich VM, Kuntsevich NV, Muminov II. Nelipidnye i protivovospalitel'nye effekty rozuvastatina u retsipientov serdtsa. Vrach. 2013; 5: 76–79.
22. Karapolat H, Engin C, Eroglu M, Yagdi T, Zoghi M, Nalbantgil S et al. Effi cacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients. Transplant Proc. 2013; 45 (9): 3381–3385. doi:10.1016/j.transproceed.2013.06.009.
Review
For citations:
Gautier S.V., Shevchenko A.O., Kormer A.Ya., Poptsov V.N., Shevchenko O.P. PROSPECTS TO IMPROVE LONG-TERM OUTCOMES OF CARDIAC TRANSPLANTATION. Russian Journal of Transplantology and Artificial Organs. 2014;16(3):23-30. (In Russ.) https://doi.org/10.15825/1995-1191-2014-3-23-30
Views:
1455
Email this article 